News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ablynx is Awarded Eur 1.8 Million Grant To Explore Novel Methods For Uses Of Nanobodies(R)


10/3/2008 9:15:47 AM

Marketwire -- GHENT, Belgium, 3 October 2008 - Ablynx [Euronext Brussels: ABLX], a pioneer in the discovery and development of Nanobodies®, a novel class of antibody-derived therapeutic proteins, today announced that it has been awarded a grant worth EUR 1.8 million by the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT).

Read at BioSpace.com

comments powered by Disqus
Ablynx
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES